Minireviews
Copyright ©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 223-229
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.223
Figure 1
Figure 1 Obesity leads to progression of chronic kidney disease through various pathways. NO: Nitric oxide; RAAS: Renal angiotensin aldosterone system; CKD: Chronic kidney disease; ESRD: End-stage renal disease.
Figure 2
Figure 2 Mechanisms of hypertension in obesity. RAAS: Renal angiotensin aldosterone system; SNS: Sympathetic nervous system.
Figure 3
Figure 3 Stepped-care approach to antihypertensive therapy in obese children. BP: Blood pressure.